Chemokine Receptor CCR1: A New Target for Progressive Kidney Disease
- 1 August 2005
- journal article
- review article
- Published by S. Karger AG in American Journal of Nephrology
- Vol. 25 (4), 365-372
- https://doi.org/10.1159/000087185
Abstract
Infiltrating leukocytes are thought to contribute to the progression of kidney disease. Locally produced chemokines guide circulating leukocytes into the kidney, which renders therapeutic blockade of respective chemokine receptors on the leukocyte surface as potential targets for the inhibition of renal leukocyte recruitment. By using mutant mice and specific antagonists, we found that chemokine receptor CCR1 has non-redundant functions for leukocyte adhesion to activated vascular endothelium and for transendothelial diapedesis. Most importantly, CCR1 blockade with a specific small molecule antagonist can improve injury in several types of progressive kidney disease models, even if treatment is initiated in advanced disease states. Identification of new targets may add to the therapeutic options in chronic kidney disease. Copyright (C) 2005 S. Karger AG, Basel.Keywords
This publication has 40 references indexed in Scilit:
- Monocytes may promote myofibroblast accumulation and apoptosis in Alport renal fibrosis11See Editorial by Nikolic-Paterson, p. 1582.Kidney International, 2003
- Chemokines and chemokine receptors are involved in the resolution or progression of renal diseaseKidney International, 2003
- Expression of the chemokines MCP-1/CCL2 and RANTES/CCL5 is differentially regulated by infiltrating inflammatory cellsKidney International, 2002
- JAM-1 is a ligand of the β2 integrin LFA-1 involved in transendothelial migration of leukocytesNature Immunology, 2002
- Fractalkine expression in human renal inflammationThe Journal of Pathology, 2001
- The Biology of Chemokines and their ReceptorsAnnual Review of Immunology, 2000
- The Role of Chemokine Receptors in Primary, Effector, and Memory Immune ResponsesAnnual Review of Immunology, 2000
- Chemokines: A New Classification System and Their Role in ImmunityImmunity, 2000
- Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritisJCI Insight, 1999
- Bindarit retards renal disease and prolongs survival in murine lupus autoimmune diseaseKidney International, 1998